Canatu: leading the charge to unlock the potential of carbon nanotubes
We initiate coverage of Canatu, a leading player in advanced carbon nanotubes (CNTs), with a Buy rating and a EUR15 price target. Recently listed post-combination with Lifeline SPAC 1 in September 2024, Canatu offers a compelling growth opportunity, well-positioned to capitalise on the commercialis
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.